UAE Farm Animal Drugs Market Growth, Trends, and Forecast to 2031

UAE Farm Animal Drugs Market Size and Forecast (2021 - 2031), Country Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Anti-Infective Drugs, Parasiticides, Anti-Inflammatory and Anesthetics, Hormones and Related Products, and Others), Animal Type (Poultry, Cattle, Horse, and Others), Route Of Administration (Oral, Topical, Parenteral, and Others), and Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacies and Drug Stores, and Others)

  • Report Date : Sep 2025
  • Report Code : TIPRE00041025
  • Category : Life Sciences
  • Status : Published
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 106

The UAE farm animal drugs market size is projected to reach US$ 25.95 million by 2031 from US$ 20.98 million in 2024. The market is expected to register a CAGR of 3.1% during 2025–2031.

UAE Farm Animal Drugs Market Analysis

The UAE farm animal drugs market is driven by increasing livestock production, poultry farming, and focus on animal health. It is also accelerated due to animal-based products like meat and dairy. Both traditional veterinary medicines and new biologics, such as vaccines, antibiotics, and growth promoters, influence the market. The government has placed strict regulations and modern farming techniques to ensure food safety and livestock health. With the UAE being a hub for trade, the number of livestock farms increases in the region. Further, the market can propel further direction with continuous development with innovations in drug formulations and animal care solutions.

UAE Farm Animal Drugs Market Overview

Local livestock production, particularly in poultry, cattle, sheep, and goats, is propelling in the UAE to reduce its dependence on imports. This has led to the demand for veterinary drugs, including antibiotics, antiparasitics, vaccines, and nutritional supplements to ensure the health and productivity of farm animals, is surging. Government support through initiatives such as the National Food Security Strategy and investment in modern farming infrastructure has further stimulated the market. The UAE has harsh climatic conditions and intensive farming methods, so the risk of disease outbreak increases, and hence the importance of preventive and therapeutic drugs for animals. Multinational and regional pharmaceutical companies are increasingly entering into alliances or distribution networks in the UAE to harness this emerging market. Thus, the UAE farm animal drugs market is expected to experience growth, supported by innovation, government backing, and an increasing emphasis on animal welfare and food safety.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

UAE Farm Animal Drugs Market: Strategic Insights

uae-farm-animal-drugs-market
Analyst Image

Mrinal

Have a question?

Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst
UAE Farm Animal Drugs Market Drivers and Opportunities

Market Drivers:

  • Increasing Demand for Livestock:

    The government has introduced strict rules and updated farming methods to ensure food safety and livestock health. The market in the UAE is poised for continued growth, as new drug formulations and animal care solutions are likely to influence its future direction.
  • Surging Government Initiatives and Regulations: 

    The UAE's aim toward food security and sustainable agriculture can be observed with government initiatives and regulations. The UAE government encourages local livestock production to reduce reliance on imported food in a region with limited arable land. Subsidies for farmers, investments in agricultural infrastructure, and backing for modern farming techniques are being promoted to encourage the use of high-quality veterinary drugs.
  • Rising Prevalence of Animal Diseases: 

    Zoonotic and infectious diseases such as avian influenza and foot-and-mouth disease can devastate poultry and cattle. For example, recent avian influenza outbreaks on local poultry farms have raised the need for vaccines and antiviral drugs to avoid significant economic losses. 

Market Opportunities:

  • Adoption of Antibiotic Alternatives:

    Antibiotic alternatives offer a major opportunity due to global worries about antimicrobial resistance and consumer demand for safer livestock products without residues. The UAE’s livestock industry, especially in poultry and dairy, faces pressure to reduce antibiotic use because of rules and public health needs. The UAE Ministry of Climate Change and Environment revealed that because of probiotics, prebiotics, organic acids, and herbal extracts the use of antibiotics in livestock had reduced by 20% since 2021.
  • Integration of Digital Health Technologies:

    Digital health technologies can help in improving precision and efficiency while managing livestock. The UAE’s growing interest in modern agriculture, due to its dry climate and need for food security, IoT, AI, and predictive analytics are being increasingly adopted in farming. In 2024, the UAE Ministry of Climate Change and Environment reported that with the use of smart sensors for real-time health monitoring helped reduce the losses from diseases by 18%. These smart sensors are adopted in more than 25% of commercial poultry and dairy farms.
  • Expansion in Vaccination and Preventive Programs:

    Livestock health and food security are being largely improved by creating awareness through vaccination and preventive programs. The UAE’s focus on sustainable agriculture and stringent biosecurity measures has increased investments in vaccination programs to combat prevalent diseases such as avian influenza and brucellosis. The UAE Ministry of Climate Change and Environment reported that vaccination coverage for poultry farms increased to 85% in 2024 from 70% in 2022. This helped reduce disease outbreaks by 22%. The spread of avian influenza in poultry farms was controlled by immunizing the livestock with multivalent vaccines.

UAE Farm Animal Drugs Market Report Segmentation Analysis

The UAE farm animal drugs market is divided into different segments to give a clearer view of how it works, its growth potential, and the latest trends. Below is the standard segmentation approach used in industry reports:

By Product Type:

  • Anti-Infective Drugs:

    The anti-infective drugs segment plays a pivotal role in addressing infectious diseases in livestock such as cattle, camels, sheep, goats, and poultry amid the country's growing emphasis on food security and animal welfare. The UAE benefits from strict quarantine and vaccination protocols that drive demand for anti-infectives in farm animals.  
  • Parasiticides:

    The parasiticides segment is driven by the need to tackle internal and external parasites in livestock, including cattle, camels, sheep, and poultry. This helps ensure food security and animal health. Parasiticides are an important part of the animal drug market. They see high demand because of common zoonotic diseases such as brucellosis, which affects 17% of global cases in the GCC. For example, Boehringer Ingelheim’s Ivomec is an endectocide that is widely used to control nematodes and ticks in cattle. It can reduce production losses by up to 20%. Additionally, government initiatives, such as Abu Dhabi’s animal health programs, and the UAE’s role as a distribution hub for companies such as Zoetis, improve livestock productivity.
  • Anti-Inflammatory and anaesthetics:

    The anti-inflammatory drugs segment is vital in addressing pain and inflammation in livestock such as cattle, camels, sheep, and poultry, driven by the nation's focus on animal welfare and food security. The UAE relies on non-steroidal anti-inflammatory drugs (NSAIDs) such as flunixin and meloxicam to manage conditions such as mastitis and lameness in dairy cattle, reducing productivity losses by up to 15%.
  • Hormones and Related Product:

    The hormones and related products segment is a vital part of the UAE farm animal drugs market, enhancing reproductive efficiency and growth in livestock such as cattle, camels, sheep, and poultry, aligning with the UAE’s focus on food security and livestock productivity. The UAE, experiencing a strong demand for hormonal treatments to boost dairy and meat production.
  • Others:

    The others segment encompasses specialized products such as nutritional supplements, antimicrobials, and diagnostic agents, vital for enhancing livestock health and productivity in animals such as cattle, camels, sheep, and poultry. The country is experiencing a growing demand for these products to address specific health challenges.

By Animal Type:

  • Poultry:

    The poultry segment is a cornerstone of the UAE farm animal drugs market, driven by the high demand for poultry products and the need to maintain flock health in a rapidly growing food sector. The country relies on drugs such as antibiotics, vaccines, and feed additives to combat diseases such as avian influenza and necrotic enteritis.
  • Cattle:

    The cattle segment is a pivotal part of the UAE farm animal drugs market, driven by the demand for dairy and meat production to support food security in a region reliant on livestock. The UAE uses drugs such as antibiotics, vaccines, and hormones to manage diseases such as mastitis and foot-and-mouth disease.
  • Horse:

    The horse segment is a significant niche in the UAE farm animal drugs market, driven by the country’s cultural affinity for equine sports, breeding, and equestrian activities. The UAE demands specialized drugs such as anti-inflammatories, analgesics, and vaccines to manage equine health issues such as colic and laminitis.
  • Others:

    The others segment includes non-traditional livestock such as camels, goats, sheep, and other minor species, vital for cultural practices and food security in the region. The UAE uses drugs such as vaccines, parasiticides, and nutritional supplements to address diseases such as brucellosis in goats and camels.

By Route Of Administration:

  • Oral
  • Topical
  • Parenteral
  • Others

By Distribution Channel:

  • Veterinary hospitals
  • Veterinary clinics
  • Pharmacies and drug stores
  • Others

By Country:

  • UAE

The growth of the farm animal drugs market in the UAE is driven by the rising prevalence of animal diseases, surging government initiatives and regulations, and increasing demand for livestock products.

UAE Farm Animal Drugs Market Report ScopeUAE Farm Animal Drugs Market Share Analysis

The UAE farm animal drugs market is growing significantly. The rising prevalence of chronic and complex animal diseases has increased the demand for farm animal drugs to maintain livestock health. Additionally, to improve the in-house livestock production and reduce the reliance on livestock imports the country is experiencing the surging demmnad for farm animal drugs. Below is a summary of market share and trends in the UAE:

1. UAE

  • Market Share:

    Holds a significant market share
  • Key Drivers:

  • Increasing Demand for Livestock Products
  • Surging Government Initiatives and Regulations
  • Rising Prevalence of Animal Diseases
  • Trends:

    Growth in Intensive and Digital Farming

UAE Farm Animal Drugs Market Players Density: Understanding Its Impact on Business Dynamics

High Market Density and Competition

Competition is strong due to the presence of established players such as Zoetis, Merck KGaA, and Boehringer Ingelheim. Regional and niche providers add to the competitive landscape across regions.

The high level of competition urges companies to stand out by offering:

  • Advanced Products
  • Product Approvals
  • Compliance with Regulatory Guidelines

Opportunities and Strategic Moves

  • Investing in biomaterials and controlled-release drug delivery systems can improve treatment outcomes and reduce dosing complexity for farmers and veterinarians. Focusing on biotechnology and recombinant vaccines, these are noted as the fastest-growing and most lucrative segments of the UAE animal vaccines market.
  • Expanding product lines to include innovative pharmaceuticals, advanced vaccines (especially recombinant vaccines), nutraceuticals, and diagnostic tools provides resilience and addresses broad customer needs.
  • Leveraging digital veterinary platforms and precision livestock farming technologies (including AI-powered and blockchain-based tools) can improve disease detection, management, and create additional differentiation in a competitive market. Adoption of digital health management systems supports compliance with new government regulations and increases operational efficiency.

Major Companies operating in the UAE Farm Animal Drugs Market are:

  1. Zoetis Inc
  2. Elanco Animal Health Inc
  3. Virbac SA
  4. Boehringer Ingelheim International GmbH
  5. Provet Nutrition
  6. VAPCO Manufacturing CO. Ltd
  7. Gulf Drug
  8. Dechra Pharmaceuticals PLC
  9. Interchemie werken
  10. Merck & Co Inc

Disclaimer: The companies listed above are not ranked in any particular order.

Other companies analyzed during the course of research:

  1. United Company for Veterinary Medicines Industry LLC (UNIVET
  2. MetroVet
  3. Biovac Veterinary Medicines Co. LLC
  4. Al Alamia Veterinary Medicine Manufacturer
  5. JoinHub Gulf Pharma
  6. Biovac Veterinary Medicines Co. LLC
  7. INTRACIN PHARMA
  8. GVC Group
  9. Neopharma's pharmaceutical
  10. Intas Animal Health
  11. Zydus Lifesciences

UAE Farm Animal Drugs Market News and Recent Developments

  • Third KYOTOBIKEN Vaccine Launched in UAE

    The company launched three bovine vaccines that are registered and available in the UAE, namely "KYOTOBIKEN„ CATTLEWIN-5K, BOVINE EPHEMERAL FEVER VACCINE・K-KB, and "KYOTOBIKEN" CALFWIN 6 COMBO LIVE VACCINE.  
  • UAE launches E-Vet Gate for complete reference to registered veterinary pharmaceutical products

    The Minister of Climate Change and the Environment inaugurated E-Vet Gate, the first digital platform in the world dedicated to veterinary products. The move aligns with MoCCAE’s mandate to implement the Federal Law No. 9 of 2017, regulating the handling, trading, marketing, and circulation of veterinary products, that aims to curb illegal activities across these processes.

UAE Farm Animal Drugs Market Report Coverage and Deliverables

The "UAE Farm Animal Drugs Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:

  • UAE Farm Animal Drugs Market size and forecast at the country level for all the key market segments covered under the scope
  • UAE Farm Animal Drugs Market trends, as well as market dynamics such as drivers, restraints, and key opportunities
  • Detailed PEST and SWOT analysis
  • UAE Farm Animal Drugs Market analysis covering key market trends, country framework, major players, regulations, and recent market developments
  • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the UAE Farm Animal Drugs Market
  • Detailed company profiles
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What would be the estimated value of the UAE farm animal drugs market by 2031?

The UAE farm animal drugs market is estimated to reach US$ 25.95 million by 2031.

Which product type segment dominated the UAE farm animal drugs market in 2024?

The Parasiticides segment dominated the market in 2024.

Which are the leading players operating in the UAE farm animal drugs market?

Zoetis Inc; Elanco Animal Health Inc; Virbac SA; Boehringer Ingelheim International GmbH; Provet Nutrition; VAPCO Manufacturing CO. Ltd; Gulf Drug; Dechra Pharmaceuticals PLC; Interchemie werken; Merck & Co Inc are among the key players operating in the UAE farm animal drugs market.

What are the factors driving the UAE farm animal drugs market?

Increasing demand for livestock products, surging government initiatives and regulations, and rising prevalence of animal diseases are among the noteworthy factors contributing to the market growth.

What is the expected CAGR of the UAE farm animal drugs market?

The UAE farm animal drugs market is estimated to register a CAGR of 3.1% during the forecast period.

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Analyst Market Outlook

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:

3.2.2 Macro-economic factor analysis:

3.2.3 Developing base number:

3.2.4 Data Triangulation:

3.2.5 Country level data:

3.3 Assumptions and Limitations

4. UAE Farm Animal Drugs Market Landscape

4.1 Overview

4.2 PEST Analysis

4.3 Average Selling Price (USD/Unit) by Product Type

4.3.1 Average Selling Pricing by Product Type

4.4 Disease Prevalence by Key Diseases, 2024

4.4.1 Disease Prevalence by Key Diseases, 2024

5. UAE Farm Animal Drugs Market – Key Market Dynamics

5.1 UAE Farm Animal Drugs Market – Key Market Dynamics

5.2 Market Drivers:

5.2.1 Increasing Demand for Livestock Products

5.2.2 Surging Government Initiatives and Regulations

5.2.3 Rising Prevalence of Animal Diseases

5.3 Market Restraints

5.3.1 Regulatory and Compliance Challenges

5.3.2 High Costs Of Advanced Medicines

5.3.3 Limited veterinary infrastructure

5.4 Market Opportunities

5.4.1 Adoption of Antibiotic Alternatives

5.4.2 Integration of Digital Health Technologies

5.4.3 Expansion in Vaccination and Preventive Programs

5.5 Future Trends

5.5.1 Shift Toward Sustainable Practices

5.5.2 Technological Advancements in Drug Delivery

5.5.3 Growth in Intensive and Digital Farming

5.6 Impact of Drivers and Restraints:

6. UAE Farm Animal Drugs Market Analysis

6.1 UAE Farm Animal Drugs Market Revenue (US$ Million), 2021–2031

6.2 UAE Farm Animal Drugs Market Forecast and Analysis

7. UAE Farm Animal Drugs Market Analysis – by Product Type

7.1 Anti-Infective Drugs

7.1.1 Overview

7.1.2 Anti-Infective Drugs: UAE Farm Animal Drugs Market – Revenue and Forecast, 2021–2031 (US$ Million)

7.2 Parasiticides

7.2.1 Overview

7.2.2 Parasiticides: UAE Farm Animal Drugs Market – Revenue and Forecast, 2021–2031 (US$ Million)

7.3 Anti-Inflammatory and anaesthetics

7.3.1 Overview

7.3.2 Anti-Inflammatory and anaesthetics: UAE Farm Animal Drugs Market – Revenue and Forecast, 2021–2031 (US$ Million)

7.4 Hormones and Related Product

7.4.1 Overview

7.4.2 Hormones and Related Product: UAE Farm Animal Drugs Market – Revenue and Forecast, 2021–2031 (US$ Million)

7.5 Others

7.5.1 Overview

7.5.2 Others: UAE Farm Animal Drugs Market – Revenue and Forecast, 2021–2031 (US$ Million)

8. UAE Farm Animal Drugs Market Analysis – by Animal Type

8.1 Poultry

8.1.1 Overview

8.1.2 Poultry: UAE Farm Animal Drugs Market – Revenue and Forecast, 2021–2031 (US$ Million)

8.2 Cattle

8.2.1 Overview

8.2.2 Cattle: UAE Farm Animal Drugs Market – Revenue and Forecast, 2021–2031 (US$ Million)

8.3 Horse

8.3.1 Overview

8.3.2 Horse: UAE Farm Animal Drugs Market – Revenue and Forecast, 2021–2031 (US$ Million)

8.4 Others

8.4.1 Overview

8.4.2 Others: UAE Farm Animal Drugs Market – Revenue and Forecast, 2021–2031 (US$ Million)

9. UAE Farm Animal Drugs Market Analysis – by Route Of Administration

9.1 Oral

9.1.1 Overview

9.1.2 Oral: UAE Farm Animal Drugs Market – Revenue and Forecast, 2021–2031 (US$ Million)

9.2 Topical

9.2.1 Overview

9.2.2 Topical: UAE Farm Animal Drugs Market – Revenue and Forecast, 2021–2031 (US$ Million)

9.3 Parenteral

9.3.1 Overview

9.3.2 Parenteral: UAE Farm Animal Drugs Market – Revenue and Forecast, 2021–2031 (US$ Million)

9.4 Others

9.4.1 Overview

9.4.2 Others: UAE Farm Animal Drugs Market – Revenue and Forecast, 2021–2031 (US$ Million)

10. UAE Farm Animal Drugs Market Analysis – by Distribution Channel

10.1 Veterinary Hospitals

10.1.1 Overview

10.1.2 Veterinary Hospitals: UAE Farm Animal Drugs Market – Revenue and Forecast, 2021–2031 (US$ Million)

10.2 Veterinary Clinics

10.2.1 Overview

10.2.2 Veterinary Clinics: UAE Farm Animal Drugs Market – Revenue and Forecast, 2021–2031 (US$ Million)

10.3 Pharmacies and Drug Stores

10.3.1 Overview

10.3.2 Pharmacies and Drug Stores: UAE Farm Animal Drugs Market – Revenue and Forecast, 2021–2031 (US$ Million)

10.4 Others

10.4.1 Overview

10.4.2 Others: UAE Farm Animal Drugs Market – Revenue and Forecast, 2021–2031 (US$ Million)

11. Competitive Landscape

11.1 Heat Map Analysis by Key Players

11.2 Company Positioning & Concentration

11.3 Company Market Share (%) Analysis, 2024

12. Industry Landscape

12.1 Overview

12.2 Product Launch, Product Approvals

12.3 Expansions, Collaboration, Merger and Acquisitions, And Other Strategic Developments

13. Company Profiles

13.1 Zoetis Inc

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Elanco Animal Health Inc

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Boehringer Ingelheim International GmbH

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Provet Nutrition

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 VAPCO Manufacturing CO. Ltd

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Gulf Drug

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Dechra Pharmaceuticals PLC

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Interchemie werken

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 Merck & Co Inc

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10........................................................................................................ Virbac SA

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

List of Tables

Table 1. UAE Farm Animal Drugs Market Segmentation

Table 2. Average Selling Price

Table 3. Disease Prevalence by Key Diseases

Table 4. UAE Farm Animal Drugs Market – Revenue, 2021–2024 (US$ Million)

Table 5. UAE Farm Animal Drugs Market – Revenue Forecast, 2025–2031 (US$ Million)

Table 6. Heat Map Analysis by Key Players

Table 7. Company Market Share (%) Analysis, 2024

Table 8. Glossary of Terms, Medical Cables Market

List of Figures

Figure 1. UAE Farm Animal Drugs Market Segmentation

Figure 2. PEST Analysis

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. UAE Farm Animal Drugs Market Revenue (US$ Million), 2021–2031

Figure 5. UAE Farm Animal Drugs Market Share (%) – by Product Type, 2024 and 2031

Figure 6. Anti-Infective Drugs: UAE Farm Animal Drugs Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 7. Parasiticides: UAE Farm Animal Drugs Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 8. Anti-Inflammatory and anesthetics: UAE Farm Animal Drugs Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 9. Hormones and Related Product: UAE Farm Animal Drugs Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 10. Others: UAE Farm Animal Drugs Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 11. UAE Farm Animal Drugs Market Share (%) – by Animal Type, 2024 and 2031

Figure 12. Poultry: UAE Farm Animal Drugs Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 13. Cattle: UAE Farm Animal Drugs Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 14. Horse: UAE Farm Animal Drugs Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 15. Others: UAE Farm Animal Drugs Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 16. UAE Farm Animal Drugs Market Share (%) – by Route Of Administration, 2024 and 2031

Figure 17. Oral: UAE Farm Animal Drugs Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 18. Topical: UAE Farm Animal Drugs Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 19. Parenteral: UAE Farm Animal Drugs Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 20. Others: UAE Farm Animal Drugs Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 21. UAE Farm Animal Drugs Market Share (%) – by Distribution Channel, 2024 and 2031

Figure 22. Veterinary Hospitals: UAE Farm Animal Drugs Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 23. Veterinary Clinics: UAE Farm Animal Drugs Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 24. Pharmacies and Drug Stores: UAE Farm Animal Drugs Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 25. Others: UAE Farm Animal Drugs Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 26. Company Positioning & Concentration

Your Key Concerns Addressed - Question & Answer
Can I view a sample of the report before purchasing?

Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

Is analyst support included with the purchase?

Absolutely - analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

What are the next steps once I place an order?

Once your order is successfully placed, you will receive a confirmation email along with your invoice.

• For published reports: You'll receive access to the report within 4-6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

Can the report be tailored to suit my specific needs?

We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we'll be happy to provide a customized proposal or scope.

In what format is the report delivered?

The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

How secure is the payment process on your platform?

Our payment process is fully secure and PCI-DSS compliant.

We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.

Do you provide special pricing for buying multiple reports?

Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we're happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you're considering, and we'll share a personalized quote.

Can I connect with your team to discuss the report before buying?

Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report's scope, methodology, customization options, or which license suits you best, we're here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

Will I get a billing invoice upon purchase?

Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we'll be happy to assist.

Is there support available if I can't access my report?

Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we'll ensure the issue is resolved quickly so you can access your report without interruption.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.